Peter J. Macchiarolo

Array ( [id] => 6659167 [patent_doc_number] => 20030134328 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-17 [patent_title] => 'Mammalian genes; related reagents' [patent_app_type] => new [patent_app_number] => 10/236055 [patent_app_country] => US [patent_app_date] => 2002-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11366 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20030134328.pdf [firstpage_image] =>[orig_patent_app_number] => 10236055 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7341472 [patent_doc_number] => 20040191252 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-30 [patent_title] => 'Therapeutic uses of complement receptor 2' [patent_app_type] => new [patent_app_number] => 10/489564 [patent_app_country] => US [patent_app_date] => 2004-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9125 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20040191252.pdf [firstpage_image] =>[orig_patent_app_number] => 10489564 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6791596 [patent_doc_number] => 20030086940 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-08 [patent_title] => 'Engineered recombinant molecule that regulates humoral and cellular effector functions of the immune system' [patent_app_type] => new [patent_app_number] => 10/225519 [patent_app_country] => US [patent_app_date] => 2002-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 18551 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20030086940.pdf [firstpage_image] =>[orig_patent_app_number] => 10225519 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6855686 [patent_doc_number] => 20030129187 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-10 [patent_title] => 'Complement pathway inhibitors binding to C5 and C5a without preventing formation of C5b' [patent_app_type] => new [patent_app_number] => 10/222464 [patent_app_country] => US [patent_app_date] => 2002-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9435 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20030129187.pdf [firstpage_image] =>[orig_patent_app_number] => 10222464 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6787181 [patent_doc_number] => 20030138420 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-24 [patent_title] => 'Method for inhibition of cerebral tissue factor mediated reperfusion damage' [patent_app_type] => new [patent_app_number] => 10/217387 [patent_app_country] => US [patent_app_date] => 2002-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11081 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20030138420.pdf [firstpage_image] =>[orig_patent_app_number] => 10217387 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7148130 [patent_doc_number] => 20040170633 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-02 [patent_title] => 'Enhancing the efficacy of immunotherapies by supplementing with complement' [patent_app_type] => new [patent_app_number] => 10/486438 [patent_app_country] => US [patent_app_date] => 2004-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9845 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20040170633.pdf [firstpage_image] =>[orig_patent_app_number] => 10486438 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6660392 [patent_doc_number] => 20030135036 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-17 [patent_title] => 'Platelet glycoprotein v gene and uses' [patent_app_type] => new [patent_app_number] => 10/212499 [patent_app_country] => US [patent_app_date] => 2002-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 14695 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20030135036.pdf [firstpage_image] =>[orig_patent_app_number] => 10212499 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6817405 [patent_doc_number] => 20030068363 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-10 [patent_title] => 'MHC conjugates useful in ameliorating autoimmunity' [patent_app_type] => new [patent_app_number] => 10/199995 [patent_app_country] => US [patent_app_date] => 2002-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 20711 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20030068363.pdf [firstpage_image] =>[orig_patent_app_number] => 10199995 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 880485 [patent_doc_number] => 07355017 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-08 [patent_title] => 'Blood group antigen fusion polypeptides and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 10/199342 [patent_app_country] => US [patent_app_date] => 2002-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14843 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/355/07355017.pdf [firstpage_image] =>[orig_patent_app_number] => 10199342 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 500860 [patent_doc_number] => 07205274 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-04-17 [patent_title] => 'Hybrid peptides modulate the immune response' [patent_app_type] => utility [patent_app_number] => 10/197000 [patent_app_country] => US [patent_app_date] => 2002-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14631 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 180 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/205/07205274.pdf [firstpage_image] =>[orig_patent_app_number] => 10197000 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6851440 [patent_doc_number] => 20030143643 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Rh antibody' [patent_app_type] => new [patent_app_number] => 10/194801 [patent_app_country] => US [patent_app_date] => 2002-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4022 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20030143643.pdf [firstpage_image] =>[orig_patent_app_number] => 10194801 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 515852 [patent_doc_number] => 07189396 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-03-13 [patent_title] => 'Delivery system using mAb 3E10 and mutants and/or functional fragments thereof' [patent_app_type] => utility [patent_app_number] => 10/192315 [patent_app_country] => US [patent_app_date] => 2002-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 14297 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/189/07189396.pdf [firstpage_image] =>[orig_patent_app_number] => 10192315 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6801568 [patent_doc_number] => 20030096733 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-22 [patent_title] => 'Novel drug targets for arthritis' [patent_app_type] => new [patent_app_number] => 10/193656 [patent_app_country] => US [patent_app_date] => 2002-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 16460 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20030096733.pdf [firstpage_image] =>[orig_patent_app_number] => 10193656 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6778179 [patent_doc_number] => 20030049260 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-13 [patent_title] => 'Method of improving cognitive function' [patent_app_type] => new [patent_app_number] => 10/191238 [patent_app_country] => US [patent_app_date] => 2002-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4224 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20030049260.pdf [firstpage_image] =>[orig_patent_app_number] => 10191238 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6851475 [patent_doc_number] => 20030143678 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Zlrr3: a human leucine-rich repeat protein' [patent_app_type] => new [patent_app_number] => 10/180738 [patent_app_country] => US [patent_app_date] => 2002-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31501 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20030143678.pdf [firstpage_image] =>[orig_patent_app_number] => 10180738 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6851022 [patent_doc_number] => 20030143225 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Combinations of anti-tissue factor antibodies and anticoagulant and/or antiplatelet agents' [patent_app_type] => new [patent_app_number] => 10/172785 [patent_app_country] => US [patent_app_date] => 2002-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 33294 [patent_no_of_claims] => 72 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20030143225.pdf [firstpage_image] =>[orig_patent_app_number] => 10172785 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6678185 [patent_doc_number] => 20030228325 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-11 [patent_title] => 'Isolated peptides which bind to HLA-B18 molecules and uses thereof' [patent_app_type] => new [patent_app_number] => 10/164078 [patent_app_country] => US [patent_app_date] => 2002-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8056 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20030228325.pdf [firstpage_image] =>[orig_patent_app_number] => 10164078 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6462051 [patent_doc_number] => 20020150558 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-17 [patent_title] => 'Use of a polypeptide as cellular receptor for adenoviruses' [patent_app_type] => new [patent_app_number] => 10/156820 [patent_app_country] => US [patent_app_date] => 2002-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10528 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0150/20020150558.pdf [firstpage_image] =>[orig_patent_app_number] => 10156820 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6847670 [patent_doc_number] => 20030166837 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Isolated molecules which complex with HLA-Cw*16 molecules, and uses thereof' [patent_app_type] => new [patent_app_number] => 10/155333 [patent_app_country] => US [patent_app_date] => 2002-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5690 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20030166837.pdf [firstpage_image] =>[orig_patent_app_number] => 10155333 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6847670 [patent_doc_number] => 20030166837 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Isolated molecules which complex with HLA-Cw*16 molecules, and uses thereof' [patent_app_type] => new [patent_app_number] => 10/155333 [patent_app_country] => US [patent_app_date] => 2002-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5690 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20030166837.pdf [firstpage_image] =>[orig_patent_app_number] => 10155333 [rel_patent_id] =>[rel_patent_doc_number] =>)